This article highlights recent developments in healthcare, including the U.S. FDA's approval of Alzheimer's and diabetes ...

A provision about insulin in the Inflation Reduction Act is conflated with a 2022 executive order by former President Joe ...

Newsom’s insulin fail. A drive by California Gov. Gavin Newsom to make low-cost insulin by spending $100 million in state ...

“Rescinding the cap on insulin at $35 only makes pharmaceutical richer and everyday Americans, including MAGA voters, seriously poorer,” Steven Bechloss—author of the Substack, America, America — ...

Inc., the nonprofit drug manufacturer contracted to produce insulin for California, has not started clinical trials or applied for approval from the federal Food and Drug Administration, both of which ...

It also caps insulin ... could impact drug prices by curbing research into cost-reduction models and suggests that reducing drug prices is not a priority for the Trump administration.

Although Mounjaro and insulin have different effects on ... This is the most serious warning from the Food and Drug Administration (FDA). It alerts doctors and patients about drug effects that ...

Biocon share price surged 4.5% during Monday's session following the clearance from the US Food and Drug Administration (US FDA) for the insulin facility of Biocon Biologics in Malaysia.

Although California's governor hoped to have the cheaper insulin available by last year, it may take at least another two years.

During his first term, Trump did establish a voluntary, time-limited model capping insulin costs at $35 per month for people on participating Medicare Part D prescription drug plans. KFF ...